Target intelligence / Profile preview

Phosphoribosylamine–glycine ligase (GARS)

Target
GARS
Molecular classification
Enzyme, Ligase (specifically forms carbon-nitrogen bonds)
01

Overview

Phosphoribosylamine–glycine ligase (GARS) is an enzyme that catalyzes the second step in purine biosynthesis, forming glycinamide ribonucleotide from ATP, 5-phospho-D-ribosylamine, and glycine. This enzymatic action is essential in the nucleotide biosynthesis pathway for both de novo synthesis of DNA and RNA precursors. In bacteria, GARS is a monofunctional enzyme encoded by the purD gene, while in higher eukaryotes, it can be part of multifuncional enzymes with other purine biosynthetic activities[1][2][3][4][5][10]. The human ortholog forms part of a trifunctional complex important for cellular growth and division. This enzyme is a potential antimicrobial drug target due to its essentiality in purine synthesis in microbes[1][7].

Other names
glycinamide ribonucleotide synthetaseGAR synthetasephosphoribosylglycinamide synthetaseglycineamide ribonucleotide synthetase2-amino-N-ribosylacetamide 5'-phosphate kinosynthase5'-phosphoribosylglycinamide synthetase
02

Biological functions

Purine biosynthesisATP-bindingCatalysis of glycinamide ribonucleotide formation
03

Disease associations

Other (essential for nucleotide biosynthesis; potential antimicrobial drug target in pathogens)

Beyond the preview

Go deeper on Phosphoribosylamine–glycine ligase (GARS).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Phosphoribosylamine–glycine ligase (GARS).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call